NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 365 filers reported holding NEKTAR THERAPEUTICS in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,560 | -45.9% | 51,311 | -47.7% | 0.00% | 0.0% |
| Q2 2023 | $56,443 | -72.1% | 98,129 | +557.8% | 0.00% | -87.5% |
| Q4 2021 | $202,000 | -24.1% | 14,917 | +0.6% | 0.01% | -38.5% |
| Q3 2021 | $266,000 | +12.2% | 14,832 | +7.3% | 0.01% | +18.2% |
| Q2 2021 | $237,000 | -30.7% | 13,820 | -19.2% | 0.01% | -31.2% |
| Q1 2021 | $342,000 | +66.0% | 17,103 | +41.3% | 0.02% | +45.5% |
| Q4 2020 | $206,000 | -5.9% | 12,100 | +487.1% | 0.01% | -63.3% |
| Q1 2018 | $219,000 | – | 2,061 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Strong Tower Advisory Services | 404,972 | $6,913,000 | 4.02% |
| GREAT POINT PARTNERS LLC | 504,691 | $9,064,000 | 2.11% |
| Camber Capital Management LP | 3,750,000 | $67,350,000 | 2.07% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,901,000 | 1.50% |
| Rhenman & Partners Asset Management AB | 950,000 | $17,062,000 | 1.20% |
| MAVERICK CAPITAL LTD | 5,838,426 | $104,858,000 | 1.06% |
| Birchview Capital, LP | 72,000 | $1,293,000 | 0.88% |
| Bellevue Group AG | 4,594,656 | $82,519,000 | 0.84% |
| CM Management, LLC | 50,000 | $898,000 | 0.67% |
| Duquesne Family Office | 1,000,000 | $17,960,000 | 0.58% |